Format
Sort by
Items per page

Send to

Choose Destination

Best matches for de los Reyes-Gavilán CG[au]:

Nutrition and the gut microbiome in the elderly. Salazar N et al. Gut Microbes. (2017)

Early microbiota, antibiotics and health. Nogacka AM et al. Cell Mol Life Sci. (2018)

Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Ríos-Covián D et al. Front Microbiol. (2016)

Search results

Items: 1 to 50 of 119

1.

Use of Fecal Slurry Cultures to Study In Vitro Effects of Bacteriocins on the Gut Bacterial Populations of Infants.

Umu ÖCO, Gueimonde M, Oostindjer M, Ovchinnikov KV, de Los Reyes-Gavilán CG, Arbulu S, Hernández PE, Martínez B, Diep DB, Salazar N.

Probiotics Antimicrob Proteins. 2019 Dec 1. doi: 10.1007/s12602-019-09614-w. [Epub ahead of print]

PMID:
31788767
2.

Functional Effects of EPS-Producing Bifidobacterium Administration on Energy Metabolic Alterations of Diet-Induced Obese Mice.

Salazar N, Neyrinck AM, Bindels LB, Druart C, Ruas-Madiedo P, Cani PD, de Los Reyes-Gavilán CG, Delzenne NM.

Front Microbiol. 2019 Aug 7;10:1809. doi: 10.3389/fmicb.2019.01809. eCollection 2019.

3.

Age-Associated Changes in Gut Microbiota and Dietary Components Related with the Immune System in Adulthood and Old Age: A Cross-Sectional Study.

Salazar N, Arboleya S, Fernández-Navarro T, de Los Reyes-Gavilán CG, Gonzalez S, Gueimonde M.

Nutrients. 2019 Jul 31;11(8). pii: E1765. doi: 10.3390/nu11081765.

4.

Fermented Dairy Foods: Impact on Intestinal Microbiota and Health-Linked Biomarkers.

González S, Fernández-Navarro T, Arboleya S, de Los Reyes-Gavilán CG, Salazar N, Gueimonde M.

Front Microbiol. 2019 May 24;10:1046. doi: 10.3389/fmicb.2019.01046. eCollection 2019.

5.

Intestinal Immunomodulation and Shifts on the Gut Microbiota of BALB/c Mice Promoted by Two Bifidobacterium and Lactobacillus Strains Isolated from Human Samples.

Nogacka AM, Oddi S, Salazar N, Reinheimer JA, Gueimonde M, Vinderola G, de Los Reyes-Gavilán CG.

Biomed Res Int. 2019 Apr 18;2019:2323540. doi: 10.1155/2019/2323540. eCollection 2019.

6.

Exploring the interactions between serum free fatty acids and fecal microbiota in obesity through a machine learning algorithm.

Fernández-Navarro T, Díaz I, Gutiérrez-Díaz I, Rodríguez-Carrio J, Suárez A, de Los Reyes-Gavilán CG, Gueimonde M, Salazar N, González S.

Food Res Int. 2019 Jul;121:533-541. doi: 10.1016/j.foodres.2018.12.009. Epub 2018 Dec 5.

PMID:
31108778
7.

Xenobiotics Formed during Food Processing: Their Relation with the Intestinal Microbiota and Colorectal Cancer.

Nogacka AM, Gómez-Martín M, Suárez A, González-Bernardo O, de Los Reyes-Gavilán CG, González S.

Int J Mol Sci. 2019 Apr 25;20(8). pii: E2051. doi: 10.3390/ijms20082051. Review.

8.

Impact of probiotics on development and behaviour in Drosophila melanogaster - a potential in vivo model to assess probiotics.

Gómez E, Martín F, Nogacka AM, Salazar N, Aláez L, Alcorta E, Gueimonde M, De Los Reyes-Gavilán CG.

Benef Microbes. 2019 Mar 13;10(2):179-188. doi: 10.3920/BM2018.0012. Epub 2018 Dec 21.

PMID:
30574803
9.

Fecal microbiota profile in a group of myasthenia gravis patients.

Moris G, Arboleya S, Mancabelli L, Milani C, Ventura M, de Los Reyes-Gavilán CG, Gueimonde M.

Sci Rep. 2018 Sep 26;8(1):14384. doi: 10.1038/s41598-018-32700-y.

10.

Could Fecal Phenylacetic and Phenylpropionic Acids Be Used as Indicators of Health Status?

Gutiérrez-Díaz I, Fernández-Navarro T, Salazar N, Bartolomé B, Moreno-Arribas MV, López P, Suárez A, de Los Reyes-Gavilán CG, Gueimonde M, González S.

J Agric Food Chem. 2018 Oct 10;66(40):10438-10446. doi: 10.1021/acs.jafc.8b04102. Epub 2018 Sep 28.

PMID:
30227707
11.

C-section and the Neonatal Gut Microbiome Acquisition: Consequences for Future Health.

Arboleya S, Suárez M, Fernández N, Mantecón L, Solís G, Gueimonde M, de Los Reyes-Gavilán CG.

Ann Nutr Metab. 2018;73 Suppl 3:17-23. doi: 10.1159/000490843. Epub 2018 Jul 24. Review.

12.

Real-time monitoring of HT29 epithelial cells as an in vitro model for assessing functional differences among intestinal microbiotas from different human population groups.

Nogacka AM, Ruas-Madiedo P, Gómez E, Solís G, Fernández N, Suárez M, Suárez A, Salazar N, de Los Reyes-Gavilán CG, Gueimonde M.

J Microbiol Methods. 2018 Sep;152:210-216. doi: 10.1016/j.mimet.2018.07.003. Epub 2018 Jul 10.

PMID:
30006229
13.

Bifidobacterium breve IPLA20005 affects in vitro the expression of hly and luxS genes, related to the virulence of Listeria monocytogenes Lm23.

Rios-Covian D, Nogacka A, Salazar N, Hernández-Barranco AM, Cuesta I, Gueimonde M, de Los Reyes Gavilán CG.

Can J Microbiol. 2018 Mar;64(3):215-221. doi: 10.1139/cjm-2017-0625. Epub 2018 Jan 3.

PMID:
29298396
14.

Early microbiota, antibiotics and health.

Nogacka AM, Salazar N, Arboleya S, Suárez M, Fernández N, Solís G, de Los Reyes-Gavilán CG, Gueimonde M.

Cell Mol Life Sci. 2018 Jan;75(1):83-91. doi: 10.1007/s00018-017-2670-2. Epub 2017 Oct 7. Review.

PMID:
28988290
15.

Free Fatty Acids Profiles Are Related to Gut Microbiota Signatures and Short-Chain Fatty Acids.

Rodríguez-Carrio J, Salazar N, Margolles A, González S, Gueimonde M, de Los Reyes-Gavilán CG, Suárez A.

Front Immunol. 2017 Jul 24;8:823. doi: 10.3389/fimmu.2017.00823. eCollection 2017.

16.

Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates.

Nogacka A, Salazar N, Suárez M, Milani C, Arboleya S, Solís G, Fernández N, Alaez L, Hernández-Barranco AM, de Los Reyes-Gavilán CG, Ventura M, Gueimonde M.

Microbiome. 2017 Aug 8;5(1):93. doi: 10.1186/s40168-017-0313-3.

17.

Different Intestinal Microbial Profile in Over-Weight and Obese Subjects Consuming a Diet with Low Content of Fiber and Antioxidants.

Fernández-Navarro T, Salazar N, Gutiérrez-Díaz I, de Los Reyes-Gavilán CG, Gueimonde M, González S.

Nutrients. 2017 May 27;9(6). pii: E551. doi: 10.3390/nu9060551.

18.

Shaping the Metabolism of Intestinal Bacteroides Population through Diet to Improve Human Health.

Rios-Covian D, Salazar N, Gueimonde M, de Los Reyes-Gavilan CG.

Front Microbiol. 2017 Mar 7;8:376. doi: 10.3389/fmicb.2017.00376. eCollection 2017. No abstract available.

19.

Intestinal Microbiota and Weight-Gain in Preterm Neonates.

Arboleya S, Martinez-Camblor P, Solís G, Suárez M, Fernández N, de Los Reyes-Gavilán CG, Gueimonde M.

Front Microbiol. 2017 Feb 8;8:183. doi: 10.3389/fmicb.2017.00183. eCollection 2017.

20.

Intestinal Dysbiosis Is Associated with Altered Short-Chain Fatty Acids and Serum-Free Fatty Acids in Systemic Lupus Erythematosus.

Rodríguez-Carrio J, López P, Sánchez B, González S, Gueimonde M, Margolles A, de Los Reyes-Gavilán CG, Suárez A.

Front Immunol. 2017 Jan 23;8:23. doi: 10.3389/fimmu.2017.00023. eCollection 2017.

21.

Resistant starch can improve insulin sensitivity independently of the gut microbiota.

Bindels LB, Segura Munoz RR, Gomes-Neto JC, Mutemberezi V, Martínez I, Salazar N, Cody EA, Quintero-Villegas MI, Kittana H, de Los Reyes-Gavilán CG, Schmaltz RJ, Muccioli GG, Walter J, Ramer-Tait AE.

Microbiome. 2017 Feb 7;5(1):12. doi: 10.1186/s40168-017-0230-5.

22.

Adherence to a Mediterranean Diet Influences the Fecal Metabolic Profile of Microbial-Derived Phenolics in a Spanish Cohort of Middle-Age and Older People.

Gutiérrez-Díaz I, Fernández-Navarro T, Salazar N, Bartolomé B, Moreno-Arribas MV, de Andres-Galiana EJ, Fernández-Martínez JL, de Los Reyes-Gavilán CG, Gueimonde M, González S.

J Agric Food Chem. 2017 Jan 25;65(3):586-595. doi: 10.1021/acs.jafc.6b04408. Epub 2017 Jan 11.

PMID:
28029051
23.

Nutrition and the gut microbiome in the elderly.

Salazar N, Valdés-Varela L, González S, Gueimonde M, de Los Reyes-Gavilán CG.

Gut Microbes. 2017 Mar 4;8(2):82-97. doi: 10.1080/19490976.2016.1256525. Epub 2016 Nov 3. Review.

24.

Bioactive compounds from regular diet and faecal microbial metabolites.

Fernández-Navarro T, Salazar N, Gutiérrez-Díaz I, Sánchez B, Rúas-Madiedo P, de Los Reyes-Gavilán CG, Margolles A, Gueimonde M, González S.

Eur J Nutr. 2018 Mar;57(2):487-497. doi: 10.1007/s00394-016-1332-8. Epub 2016 Oct 15.

PMID:
27744545
25.

Editorial: Insights into Microbe-Microbe Interactions in Human Microbial Ecosystems: Strategies to Be Competitive.

Salazar N, de Los Reyes-Gavilán CG.

Front Microbiol. 2016 Sep 23;7:1508. eCollection 2016. No abstract available.

26.

Bacteroides fragilis metabolises exopolysaccharides produced by bifidobacteria.

Rios-Covian D, Cuesta I, Alvarez-Buylla JR, Ruas-Madiedo P, Gueimonde M, de Los Reyes-Gavilán CG.

BMC Microbiol. 2016 Jul 15;16(1):150. doi: 10.1186/s12866-016-0773-9.

27.

A proteomic approach towards understanding the cross talk between Bacteroides fragilis and Bifidobacterium longum in coculture.

Rios-Covián D, Sánchez B, Martínez N, Cuesta I, Hernández-Barranco AM, de Los Reyes-Gavilán CG, Gueimonde M.

Can J Microbiol. 2016 Jul;62(7):623-8. doi: 10.1139/cjm-2015-0804. Epub 2016 Mar 4.

PMID:
27156738
28.

Impact of Prematurity and Perinatal Antibiotics on the Developing Intestinal Microbiota: A Functional Inference Study.

Arboleya S, Sánchez B, Solís G, Fernández N, Suárez M, Hernández-Barranco AM, Milani C, Margolles A, de Los Reyes-Gavilán CG, Ventura M, Gueimonde M.

Int J Mol Sci. 2016 Apr 29;17(5). pii: E649. doi: 10.3390/ijms17050649.

29.

Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health.

Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilán CG, Salazar N.

Front Microbiol. 2016 Feb 17;7:185. doi: 10.3389/fmicb.2016.00185. eCollection 2016. Review.

30.

Glucolytic fingerprinting reveals metabolic groups within the genus Bifidobacterium: an exploratory study.

Rios-Covián D, Sánchez B, Cuesta I, Cueto-Díaz S, Hernández-Barranco AM, Gueimonde M, De los Reyes-Gavilán CG.

Benef Microbes. 2016;7(2):265-73. doi: 10.3920/BM2015.0129. Epub 2016 Feb 3.

PMID:
26839073
31.

Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis.

Rios-Covian D, Gueimonde M, Duncan SH, Flint HJ, de los Reyes-Gavilan CG.

FEMS Microbiol Lett. 2015 Nov;362(21). pii: fnv176. doi: 10.1093/femsle/fnv176. Epub 2015 Sep 28.

PMID:
26420851
32.

Different metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteria.

Rios-Covian D, Sánchez B, Salazar N, Martínez N, Redruello B, Gueimonde M, de Los Reyes-Gavilán CG.

Front Microbiol. 2015 Aug 18;6:825. doi: 10.3389/fmicb.2015.00825. eCollection 2015.

33.

Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice.

Bindels LB, Neyrinck AM, Salazar N, Taminiau B, Druart C, Muccioli GG, François E, Blecker C, Richel A, Daube G, Mahillon J, de los Reyes-Gavilán CG, Cani PD, Delzenne NM.

PLoS One. 2015 Jun 22;10(6):e0131009. doi: 10.1371/journal.pone.0131009. eCollection 2015.

34.

Role of microorganisms present in dairy fermented products in health and disease.

de los Reyes-Gavilán CG, Fernández M, Hudson JA, Korpela R.

Biomed Res Int. 2015;2015:204173. doi: 10.1155/2015/204173. Epub 2015 Mar 19. No abstract available.

35.

Impact on human health of microorganisms present in fermented dairy products: an overview.

Fernández M, Hudson JA, Korpela R, de los Reyes-Gavilán CG.

Biomed Res Int. 2015;2015:412714. doi: 10.1155/2015/412714. Epub 2015 Mar 9. Review.

36.

Production of immune response mediators by HT-29 intestinal cell-lines in the presence of Bifidobacterium-treated infant microbiota.

Arboleya S, Bahrami B, Macfarlane S, Gueimonde M, Macfarlane GT, de los Reyes-Gavilán CG.

Benef Microbes. 2015;6(4):543-52. doi: 10.3920/BM2014.0111. Epub 2015 Apr 22.

PMID:
25691102
37.

Exopolysaccharides Produced by Lactic Acid Bacteria and Bifidobacteria as Fermentable Substrates by the Intestinal Microbiota.

Salazar N, Gueimonde M, de Los Reyes-Gavilán CG, Ruas-Madiedo P.

Crit Rev Food Sci Nutr. 2016 Jul 3;56(9):1440-53. doi: 10.1080/10408398.2013.770728. Review.

PMID:
25675369
38.

The establishment of the infant intestinal microbiome is not affected by rotavirus vaccination.

Ang L, Arboleya S, Lihua G, Chuihui Y, Nan Q, Suarez M, Solís G, de los Reyes-Gavilán CG, Gueimonde M.

Sci Rep. 2014 Dec 10;4:7417. doi: 10.1038/srep07417.

39.

The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations.

Salazar N, Arboleya S, Valdés L, Stanton C, Ross P, Ruiz L, Gueimonde M, de Los Reyes-Gavilán CG.

Front Genet. 2014 Nov 21;5:406. doi: 10.3389/fgene.2014.00406. eCollection 2014. Review.

40.

Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics.

Arboleya S, Sánchez B, Milani C, Duranti S, Solís G, Fernández N, de los Reyes-Gavilán CG, Ventura M, Margolles A, Gueimonde M.

J Pediatr. 2015 Mar;166(3):538-44. doi: 10.1016/j.jpeds.2014.09.041. Epub 2014 Oct 25.

PMID:
25444008
41.

Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.

Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P.

World J Gastroenterol. 2014 Nov 7;20(41):15163-76. doi: 10.3748/wjg.v20.i41.15163. Review.

42.

Immune modulating capability of two exopolysaccharide-producing Bifidobacterium strains in a Wistar rat model.

Salazar N, López P, Garrido P, Moran J, Cabello E, Gueimonde M, Suárez A, González C, de los Reyes-Gavilán CG, Ruas-Madiedo P.

Biomed Res Int. 2014;2014:106290. doi: 10.1155/2014/106290. Epub 2014 May 29.

43.

Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women.

Salazar N, Dewulf EM, Neyrinck AM, Bindels LB, Cani PD, Mahillon J, de Vos WM, Thissen JP, Gueimonde M, de Los Reyes-Gavilán CG, Delzenne NM.

Clin Nutr. 2015 Jun;34(3):501-7. doi: 10.1016/j.clnu.2014.06.001. Epub 2014 Jun 11.

PMID:
24969566
44.

Pilot study of diet and microbiota: interactive associations of fibers and polyphenols with human intestinal bacteria.

Cuervo A, Valdés L, Salazar N, de los Reyes-Gavilán CG, Ruas-Madiedo P, Gueimonde M, González S.

J Agric Food Chem. 2014 Jun 11;62(23):5330-6. doi: 10.1021/jf501546a. Epub 2014 May 30.

PMID:
24877654
45.

Microbial targets for the development of functional foods accordingly with nutritional and immune parameters altered in the elderly.

Salazar N, López P, Valdés L, Margolles A, Suárez A, Patterson AM, Cuervo A, de los Reyes-Gavilán CG, Ruas-Madiedo P, Gonzalez S, Gueimonde M.

J Am Coll Nutr. 2013;32(6):399-406. doi: 10.1080/07315724.2013.827047.

PMID:
24606713
46.

Interactions between Bifidobacterium and Bacteroides species in cofermentations are affected by carbon sources, including exopolysaccharides produced by bifidobacteria.

Rios-Covian D, Arboleya S, Hernandez-Barranco AM, Alvarez-Buylla JR, Ruas-Madiedo P, Gueimonde M, de los Reyes-Gavilan CG.

Appl Environ Microbiol. 2013 Dec;79(23):7518-24. doi: 10.1128/AEM.02545-13. Epub 2013 Sep 27.

47.

Fatty acids intake and immune parameters in the elderly.

González S, López P, Margolles A, Suárez A, Patterson AM, Cuervo A, de los Reyes-Gavilán CG, Gueimonde M.

Nutr Hosp. 2013 Mar-Apr;28(2):474-8. doi: 10.3305/nh.2013.28.2.6183.

48.

In vitro evaluation of the impact of human background microbiota on the response to Bifidobacterium strains and fructo-oligosaccharides.

Arboleya S, Salazar N, Solís G, Fernández N, Gueimonde M, de los Reyes-Gavilán CG.

Br J Nutr. 2013 Dec 14;110(11):2030-6. doi: 10.1017/S0007114513001487. Epub 2013 May 31.

PMID:
23721811
49.

Insights into the ropy phenotype of the exopolysaccharide-producing strain Bifidobacterium animalis subsp. lactis A1dOxR.

Hidalgo-Cantabrana C, Sánchez B, Moine D, Berger B, de Los Reyes-Gavilán CG, Gueimonde M, Margolles A, Ruas-Madiedo P.

Appl Environ Microbiol. 2013 Jun;79(12):3870-4. doi: 10.1128/AEM.00633-13. Epub 2013 Apr 12.

50.

Immune Modulation Capability of Exopolysaccharides Synthesised by Lactic Acid Bacteria and Bifidobacteria.

Hidalgo-Cantabrana C, López P, Gueimonde M, de Los Reyes-Gavilán CG, Suárez A, Margolles A, Ruas-Madiedo P.

Probiotics Antimicrob Proteins. 2012 Dec;4(4):227-37. doi: 10.1007/s12602-012-9110-2.

PMID:
26782182

Supplemental Content

Loading ...
Support Center